FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
- Posted on August 1, 2026
- By NPR
- 0 Views
- 1 min read
In brief
Generating AI summary…
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.